Sangamo Biosciences, Inc. (SGMO) Posts Q1 Loss of 14c/Share

Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q1 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $3.2 million versus the consensus estimate of $3.38 million.

For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• Cintas beats estimates but stock edges lower
• General Mills beats estimates as cost savings offset volumes